10-47999702-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001137548.3(FAM25C):c.64G>A(p.Glu22Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 10/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E22Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_001137548.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 5AN: 150614Hom.: 0 Cov.: 20 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000230 AC: 32AN: 1392488Hom.: 0 Cov.: 31 AF XY: 0.0000233 AC XY: 16AN XY: 686928
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000332 AC: 5AN: 150614Hom.: 0 Cov.: 20 AF XY: 0.0000136 AC XY: 1AN XY: 73456
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.64G>A (p.E22K) alteration is located in exon 1 (coding exon 1) of the FAM25C gene. This alteration results from a G to A substitution at nucleotide position 64, causing the glutamic acid (E) at amino acid position 22 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at